News
Citigroup Says This Obesity Drugmaker's Stock Is Now a Buy
Congratulations are (still) in order for pharmaceutical giants Novo Nordisk (NYSE: NVO) and Eli Lilly (NYSE: LLY). Lilly's Zepbound and Mounjaro along with Novo's Saxenda and Wegovy remain the
EQS-News: Rubean AG: Revenue almost tripled in the first nine months of 2025
Roku Stock Rises on Outlook. Is It Time to Buy the Stock?
Roku (NASDAQ: ROKU) shares plunged immediately after the company reported its Q3 earnings report, only to furiously rally after the market opened. After the roller coaster ride, the stock now finds
Why Shopify Stock Jumped 17% in October
Shopify (NASDAQ: SHOP) stock soared 17% in October, according to data provided by S&P Global Market Intelligence. The e-commerce software provider benefited from improving market sentiment about
Why USA Rare Earth Stock Soared, Slumped, and Ended Up 13% Higher in October
Welcome to the wild ride that is USA Rare Earth (NASDAQ: USAR) stock. The stock rose 13.1% in October, according to data provided by S&P Global Market Intelligence. While that sounds relatively
Wingstop (WING) Q3 2025 Earnings Call Transcript
Image source: The Motley Fool.
Tuesday, November 4, 2025 at 10:00 a.m. ET
Chief Executive Officer — Michael Skipworth
Source Fool.com
Here's Why Elon Musk Just Downplayed Tesla's Prospects (Yes, You Read That Correctly)
The bull and bear debate over Tesla (NASDAQ: TSLA) is often framed in narrative terms. The salmon-grabbing bears usually classify Tesla as just a car company and wave a hand in the general direction
Amazon Is One of My Favorite Stocks to Evaluate
Lately, Wall Street has been very optimistic about Amazon (NASDAQ: AMZN). Of the 73 analysts covering the stock, 59 have "Buy" ratings, 11 have "Overweight" ratings, and three say "Hold."
Here's why
My 5 Top-Ranked Stocks to Buy Now in November
We are in the homestretch of 2025 -- November marks the midpoint of the fourth quarter, which means it's nearly time to start considering the portfolio steps you want to take to prepare for the end
3 Monster Stocks to Hold for the Next 3 Years
As the S&P 500 hovers near its record highs, it might seem like a risky time to buy more growth stocks. But if you plan to hold your stocks for at least a few years, it's still a great time to dip
Here's Exactly How to Calculate Your 2025 Required Minimum Distributions (RMDs)
With the holiday season just weeks away, you probably want to focus your attention on parties, gifts, and maybe some upcoming vacations. But if you're 73 or older and you haven't yet taken your
Why Sweetgreen Stock Lost 21% in October
Shares of Sweetgreen (NYSE: SG) were among the losers last month, even as there was no major news out on the fast-casual salad slinger.
Instead, a growing sense of malaise around consumer spending
Why Is Wall Street So Bearish on Beyond Meat? There's 1 Key Reason.
Plant-based meat company Beyond Meat (NASDAQ: BYND) doesn't have a single buy rating from Wall Street analysts. Instead, a mix of hold, underperform, and sell ratings makes it clear that Wall Street
With the "Magnificent Seven" at 35% of the S&P 500 and the "Ten Titans" at 40%, Are AI Growth Stocks Poised for a Sell-Off or Is There Still Room to Run?
For over a decade, the simplest way to outperform the S&P 500 has been hiding in plain sight: mega cap growth stocks.
In 2018, Apple became the first U.S. company to surpass $1 trillion in market
Why Teladoc Stock Zoomed Almost 12% Higher in October
Teladoc Health (NYSE: TDOC) has been a beaten-down stock for so long, it's almost surprising when it hits a bullish period. That's what happened in October to the telemedicine specialist, with its
This Company Now Has the World's No. 1 Drug. Should You Invest $1,000?
Eli Lilly (NYSE: LLY) manufactures a drug called tirzepatide, a GLP-1 dual receptor agonist, which it sells as Mounjaro for treating type 2 diabetes and Zepbound for weight loss. Tirzepatide became
Investment Manager Exits Valaris After 30% Stock Drop Amid Offshore Sector Weakness
On Tuesday, Massachusetts-based Lane Generational fully exited its position in Valaris Limited (NYSE:VAL), selling 71,869 shares for an estimated $3 million, according to an SEC filing for the
Where Will CoreWeave Stock Be in 5 Years?
CoreWeave (NASDAQ: CRWV), a provider of cloud-based AI infrastructure services, was one of the hottest growth stocks of 2025. It went public in March at $40, and it now trades at about $130. It
Palantir's Blowout Quarter Changes the Story. What Should Investors Do Now?
After a run that has already transformed the stock this year, Palantir (NASDAQ: PLTR) just put up the kind of quarter bulls wanted to see. Yet shares fell sharply the day after the report, as
Robinhood Is Quietly Building a Fintech Ecosystem for the Next Generation
Robinhood (NASDAQ: HOOD) has long been known for changing how people trade stocks. But the company's next act might prove more meaningful -- and less visible.
After years of being labelled a
3 High-Yield Stock ETFs to Buy With $500 and Hold Forever
You'll have plenty of options to consider if you have $500 to put to work and you want to buy a high-yield exchange-traded fund (ETF). But three stand out from the pack as buy-and-hold
Why AppLovin Stock Lost 11% in October
AppLovin (NASDAQ: APP) has been one of the more volatile stocks on the market over the last year or two, and that pattern continued in October as the high-flying adtech stock was hit by reports of
CEO Jensen Huang Just Delivered Fantastic News for Nvidia Investors
Nvidia (NASDAQ: NVDA) made headlines at its GTC event that was held on Oct. 28. There were several bombshell announcements ranging from government contracts to quantum computing to new technology
Investor Cuts Stake in Coeur Mining by $4 Million Amid Stock's 130% Rally and New Gold Deal
Massachusetts-based Lane Generational reported reducing its position in Coeur Mining (NYSE:CDE) by 311,499 shares worth an estimated $3.8 million, according to its SEC filing for the period ended
Can Cardano Reach $1?
Round numbers aren't magical, but they tend to concentrate attention, catalyze headlines, and, when the fundamentals line up, they can contribute to pulling new capital into an asset. With that in



